Chronic inhibition of neutral endopeptidase reduces left ventricular hypertrophy without changing blood pressure in spontaneously hypertensive rats.
Monopoli
A
A
Research Laboratories, Schering-Plough SpA, Comazzo MI, Italy.
Forlani
A
A
Ongini
E
E
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D006332:Cardiomegaly / Q000209:etiology / Q000473:pathology*; D004148:Dioxolanes / Q000494:pharmacology; D004151:Dipeptides / Q000494:pharmacology; D004656:Enalapril / Q000031:analogs & derivatives / Q000494:pharmacology; D006973:Hypertension / Q000150:complications / Q000503:physiopathology*; D008715:Methionine / Q000031:analogs & derivatives*; D009206:Myocardium / Q000473:pathology; D015260:Neprilysin / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D051381:Rats; D011918:Rats, Inbred SHR
D000806:Angiotensin-Converting Enzyme Inhibitors; D004148:Dioxolanes; D004151:Dipeptides; C056319:Sch 34826; C069018:SCH 42495; D004656:Enalapril; C052555:spirapril; D008715:Methionine; D015260:Neprilysin